Owner Rigel Pharmaceuticals, Inc.

Inventors Singh, Rajinder; Kolluri, Rao; Payan, Donald G.; Tso, Kin; Zhao, Haoran; Gu, Shihai; Ramphal, John; Li, Hui

Agent FB Rice

Pub. Number AU-A-2008275918

PCT Pub. Number WO2009/012421

Priority 60/950,309 17.07.07 US; 61/049,750 01.05.08 US; 60/985,184 02.11.07 US

Filing date 17 July 2008

Wipo publication date 22 January 2009

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms